UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Gastrointestinal hormones and bariatric surgery‐induced weight loss

Obesity (Silver Spring, Md.), 2013-06, Vol.21 (6), p.1093-1103

2013

Volltextzugriff (PDF)

Mechanisms responsible for excess weight loss after bariatric surgery

Journal of diabetes science and technology, 2011-09, Vol.5 (5), p.1263-1282

2011

Volltextzugriff (PDF)

Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog

Obesity (Silver Spring, Md.), 2014-05, Vol.22 (5), p.1238-1245

2014

Volltextzugriff (PDF)

Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs

Diabetes (New York, N.Y.), 2005-03, Vol.54 (3), p.862-871

2005

Volltextzugriff (PDF)

CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors

American journal of physiology: endocrinology and metabolism, 2015-10, Vol.309 (8), p.E747-E758

2015

Volltextzugriff (PDF)

Exenatide Sensitizes Insulin-Mediated Whole-Body Glucose Disposal and Promotes Uptake of Exogenous Glucose by the Liver

Diabetes (New York, N.Y.), 2009-02, Vol.58 (2), p.352-359

2009

Volltextzugriff (PDF)

Exenatide Treatment Alone Improves [beta]-Cell Function in a Canine Model of Pre-Diabetes

PloS one, 2016-07, Vol.11 (7)

2016

Volltextzugriff (PDF)

Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes

PloS one, 2016-07, Vol.11 (7), p.e0158703

2016

Volltextzugriff (PDF)

Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA

PloS one, 2011-03, Vol.6 (3), p.e18134-e18134

2011

Volltextzugriff (PDF)

High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets

PloS one, 2015-04, Vol.10 (4), p.e0123558-e0123558

2015

Volltextzugriff (PDF)

Corrections: High-Fat Diet-Induced Insulin Resistance does not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets

PloS one, 2015-06, Vol.10 (6), p.e0131033-e0131033

2015

Volltextzugriff (PDF)

Failure of Homeostatic Model Assessment of Insulin Resistance to Detect Marked Diet-Induced Insulin Resistance in Dogs

Diabetes (New York, N.Y.), 2014-06, Vol.63 (6), p.1914-1919

2014

Volltextzugriff (PDF)

Gastrointestinal hormones and bariatric surgery-induced weight loss: Gut Hormones and Bariatric Surgery

Obesity (Silver Spring, Md.), 2013-06, Vol.21 (6), p.1093-1103

2013

Volltextzugriff (PDF)

Exenatide can reduce glucose independent of islet hormones or gastric emptying

American journal of physiology: endocrinology and metabolism, 2008-08, Vol.295 (2), p.E269-E277

2008

Volltextzugriff (PDF)

Lipid-induced insulin resistance does not impair insulin access to skeletal muscle

American journal of physiology: endocrinology and metabolism, 2015-06, Vol.308 (11), p.E1001-E1009

2015

Volltextzugriff (PDF)

Novel canine models of obese prediabetes and mild type 2 diabetes

American journal of physiology: endocrinology and metabolism, 2010-01, Vol.298 (1), p.E38-E48

2010

Volltextzugriff (PDF)

Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia

American journal of physiology: endocrinology and metabolism, 2014-10, Vol.307 (8), p.E644-E652

2014

Volltextzugriff (PDF)

CB 1 antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs

American journal of physiology: endocrinology and metabolism, 2012-05, Vol.302 (10), p.E1261-E1268

2012

Volltextzugriff (PDF)

Large Size Cells in the Visceral Adipose Depot Predict Insulin Resistance in the Canine Model

Obesity (Silver Spring, Md.), 2011-11, Vol.19 (11), p.2121-2129

2011

Volltextzugriff (PDF)

CB1 antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs

American journal of physiology: endocrinology and metabolism, 2012-05, Vol.302 (10), p.E1261-E1268

2012

Volltextzugriff (PDF)

Essentiality of Portal Vein Receptors in Hypoglycemic Counterregulation: Direct Proof Via Denervation in Male Canines

Endocrinology (Philadelphia), 2014-04, Vol.155 (4), p.1247-1254

2014

Volltextzugriff (PDF)

Increase in visceral fat per se does not induce insulin resistance in the canine model

Obesity (Silver Spring, Md.), 2015-01, Vol.23 (1), p.105-111

2015

Volltextzugriff (PDF)

Estimating Hepatic Glucokinase Activity Using a Simple Model of Lactate Kinetics

Diabetes care, 2012-05, Vol.35 (5), p.1015-1020

2012

Volltextzugriff (PDF)

Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal

American journal of physiology: endocrinology and metabolism, 2010-02, Vol.298 (2), p.E346-E353

2010

Volltextzugriff (PDF)

Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal

American journal of physiology: endocrinology and metabolism, 2010, Vol.61 (2)

2010

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Gastrointestinal hormones and bariatric surgery‐induced weight loss

Mechanisms responsible for excess weight loss after bariatric surgery

Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog

Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs

CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors

Exenatide Sensitizes Insulin-Mediated Whole-Body Glucose Disposal and Promotes Uptake of Exogenous Glucose by the Liver

Exenatide Treatment Alone Improves [beta]-Cell Function in a Canine Model of Pre-Diabetes

Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes

Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA

High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets

Corrections: High-Fat Diet-Induced Insulin Resistance does not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets

Failure of Homeostatic Model Assessment of Insulin Resistance to Detect Marked Diet-Induced Insulin Resistance in Dogs

Gastrointestinal hormones and bariatric surgery-induced weight loss: Gut Hormones and Bariatric Surgery

Exenatide can reduce glucose independent of islet hormones or gastric emptying

Lipid-induced insulin resistance does not impair insulin access to skeletal muscle

Novel canine models of obese prediabetes and mild type 2 diabetes

Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia

CB 1 antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs

Large Size Cells in the Visceral Adipose Depot Predict Insulin Resistance in the Canine Model

CB1 antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs

Essentiality of Portal Vein Receptors in Hypoglycemic Counterregulation: Direct Proof Via Denervation in Male Canines

Increase in visceral fat per se does not induce insulin resistance in the canine model

Estimating Hepatic Glucokinase Activity Using a Simple Model of Lactate Kinetics

Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal

Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal

Suchergebnisse filtern